Collaboration between prevention and harm reduction can improve health outcomes and expand the reach of services. Harm reduction touches services across the behavioral health continuum of care and can align with prevention strategies. This product explains the importance of collaboration between prevention and harm reduction and identifies potential collaborative opportunities and partners. To view/download the […]
Harm reduction
Central East ATTC Event
Introduction to the National Enhanced CLAS Standards: Understanding Disparities and Building Health Equity (Culturally and Linguistically Appropriate Services) Part 4 Contingency Management and Stimulant Use Webinar Series Session 4: Roundtable and Case Example Exploration Contingency Management and Stimulant Use Webinar Series Session 1: Foundations Fostering Family Acceptance with Parents and Caregivers of LGBTQ Youth […]
Central East PTTC event
Implementing Actionable Leadership-Session 2: Discovering Your Own Unique Leadership Style https://umsystem.zoom.us/meeting/register/tJIqc-CopjkiG92Eom16rydAMjNmj5ZSB5-b#/registration https://umsystem.zoom.us/meeting/register/tJEtc-GpqzkqGdYm_89qWUezVhfPcxXmy8lQ#/registration ehavioral Health Providers to Address and Prevent Addiction https://pttcnetwork.org/event/stigma-and-substance-use-prevention-part-1-the-impacts-of-stigma-2/ Understanding Addiction: Moving Throughout the Spectrum of Mental, Emotional, and Behavioral Interventions Identifying and Addressing Substance Use Trends in the United States and the Central East Region The Ethics of Authentic […]
Opioid pain meds get new safety warning
From MedPage Today All Opioid Pain Meds to Get New Safety Warnings, FDA Says — Updated labeling to include warning about opioid-induced hyperalgesia The FDA is making several updates to the prescribing information for opioid pain medications to provide guidance on safe use, according to a Drug Safety Communicationopens in a new tab or window, […]
FDA to Restrict Xylazine
From the FDA February 28, 2023 FDA Takes Action to Restrict Unlawful Import of Xylazine Agency Aims to Maintain Availability for Legitimate Use in Animals while Preventing Importation for Illicit Purposes Today, the U.S. Food and Drug Administration announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients and finished dosage […]